Xenon Pharmaceuticals (XENE) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts XENE Hot Sheet
Join SI Premium – FREE
Xenon Pharmaceuticals (NASDAQ: XENE) reported Q4 EPS of ($0.84), $0.01 better than the analyst estimate of ($0.85).
For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Tesla Nears Unveiling of Radical New ‘Flying’ Roadster - The Information
- Regeneron Pharma (REGN) PT Raised to $756 at Bernstein SocGen Group
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
